The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 09, 2015

Filed:

Apr. 28, 2005
Applicants:

Takayuki Yoshida, Tokyo, JP;

Hiroaki Tasaki, Tokyo, JP;

Masataka Katsuma, Tokyo, JP;

Atsushi Maeda, Tokyo, JP;

Inventors:

Takayuki Yoshida, Tokyo, JP;

Hiroaki Tasaki, Tokyo, JP;

Masataka Katsuma, Tokyo, JP;

Atsushi Maeda, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A61K 31/135 (2006.01); A61K 47/02 (2006.01); A61K 47/04 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01); A61K 47/42 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/50 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0056 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 9/5078 (2013.01); A61K 31/135 (2013.01); A61K 9/2081 (2013.01); A61K 9/501 (2013.01); A61K 9/5015 (2013.01); A61K 9/5026 (2013.01); A61K 9/5042 (2013.01); A61K 9/5047 (2013.01);
Abstract

The present invention relates to an oral pharmaceutical composition in particle form, which comprises particles that contain a drug at the core of the pharmaceutical composition in particle form; a middle layer that contains two types of water-soluble components, an insolubilizer and an insolubilizing substance; and an outer layer for controlling water penetration that contains a water-insoluble substance. The present invention makes it possible to provide a pharmaceutical composition in particle form for oral use with which initial drug release is suppressed, the drug is quickly released thereafter, and lag time can be controlled as needed, and fast-disintegrating tablets containing this composition.


Find Patent Forward Citations

Loading…